Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of RMJH-111b to Treat Essential Hypertension
Phase 1
Completed
- Conditions
- Essential Hypertension
- Interventions
- Drug: Placebo soft gelatin capsuleDrug: Magnesium citrate, tribasic anhydrous soft gelatin capsule
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- RMJ Holdings, LLC
- Target Recruit Count
- 22
- Registration Number
- NCT02822222
- Locations
- πΊπΈ
Orange County Research Center, Tustin, California, United States
News
No news found